NDC 0069-1501 – Talzenna
Talazoparib Tosylate .5 mg/1 · Capsule · Oral
Product NDC0069-1501
Product details
- Brand name
- Talzenna
- Generic name
- Talazoparib
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- NDA · NDA211651
- Marketed since
- January 31, 2022
- Marketing end
- March 31, 2027
- Pharmacologic class
- Poly(ADP-Ribose) Polymerase Inhibitor
Active ingredients
- Talazoparib Tosylate .5 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0069-1501-30 | 1 BOTTLE in 1 CARTON (0069-1501-30) / 30 CAPSULE in 1 BOTTLE | Jan 31, 2022 |
Other Talzenna products
- 0069-0296 Talazoparib Tosylate .25 mg/1 · Capsule · Pfizer Laboratories Div Pfizer Inc
- 0069-1195 Talazoparib Tosylate 1 mg/1 · Capsule · Pfizer Laboratories Div Pfizer Inc
- 63539-295 Talazoparib Tosylate 1 mg/1 · Capsule · U.S. Pharmaceuticals
- 0069-0252 Talazoparib Tosylate .1 mg/1 · Capsule, Liquid Filled · Pfizer Laboratories Div Pfizer Inc
- 0069-0353 Talazoparib Tosylate .25 mg/1 · Capsule, Liquid Filled · Pfizer Laboratories Div Pfizer Inc
- 0069-0454 Talazoparib Tosylate .35 mg/1 · Capsule, Liquid Filled · Pfizer Laboratories Div Pfizer Inc
- 0069-0546 Talazoparib Tosylate .5 mg/1 · Capsule, Liquid Filled · Pfizer Laboratories Div Pfizer Inc
- 0069-0655 Talazoparib Tosylate .75 mg/1 · Capsule, Liquid Filled · Pfizer Laboratories Div Pfizer Inc
- 0069-0757 Talazoparib Tosylate 1 mg/1 · Capsule, Liquid Filled · Pfizer Laboratories Div Pfizer Inc
- 63539-025 Talazoparib Tosylate .5 mg/1 · Capsule, Liquid Filled · U.S. Pharmaceuticals
- 63539-031 Talazoparib Tosylate 1 mg/1 · Capsule, Liquid Filled · U.S. Pharmaceuticals